- Docetaxel-Cisplatin-5-FU Combination Chemotherapy as a First-line Treatment in Patients with Metastatic or Recurred Gastric Cancer
-
Kim JH, Lee YC
- KMID: 782915
- Korean J Gastroenterol.
- 2007 Sep;50(3):207-209.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Modification of adriamycin-induced cytotoxicity by recombinant human interferon-gamma and/or verapamil in human stomach cancer cells
-
Hong WS, Kim CM, Lee CT, Lee JO, Kang TW
- KMID: 1421919
- J Korean Med Sci.
- 1992 Sep;7(3):236-240.
- doi: 10.3346/jkms.1992.7.3.236
Recombinant human-interferon-gamma (rH-IFN-gamma) and verapamil (VRP), either alone or in combination, were evaluated in MTT assay for their modification effects on adriamycin-induced cytotoxicity against MKN-45, human stomach adenocarcinoma cells.... -
- CITED
-
- Close
- SHARE
-
- Close
- S-1 Monotherapy as a Neoadjuvant Treatment for Locally Advanced Gastric Cancer
-
Jung JY, Rha SY, Ahn JB, Yang WI, Noh SH, Chung HC, Jeung HC
- KMID: 1382660
- Korean J Intern Med.
- 2008 Mar;23(1):37-41.
- doi: 10.3904/kjim.2008.23.1.37
S-1, a novel oral fluoropyrimidine, is an effective therapeutic agent for gastric cancer. Herein, we report a case with locally advanced gastric cancer that achieved a curative resection after S-1... -
- CITED
-
- Close
- SHARE
-
- Close
- Astaxanthin Inhibits Proliferation of Human Gastric Cancer Cell Lines by Interrupting Cell Cycle Progression
-
Kim JH, Park JJ, Lee BJ, Joo MK, Chun HJ, Lee SW, Bak YT
- KMID: 2411963
- Gut Liver.
- 2016 May;10(3):369-374.
- doi: 10.5009/gnl15208
BACKGROUND/AIMS: Astaxanthin is a carotenoid pigment that has antioxidant, antitumoral, and anti-inflammatory properties. In this in vitro study, we investigated the mechanism of anticancer effects of astaxanthin in gastric carcinoma... -
- CITED
-
- Close
- SHARE
-
- Close
- Docetaxel-Cisplatin-5-FU Combination Chemotherapy as a First-line Treatment in Patients with Metastatic or Recurred Gastric Cancer
-
Kang SH, Kim JI, Goh PG, Hwang SW, Kwon DS, Nam KW, Kang HM, Kang YS, Moon HS, Kim SH, Seong JK, Lee BS, Jeong HY
- KMID: 782906
- Korean J Gastroenterol.
- 2007 Sep;50(3):157-163.
BACKGROUND/AIMS: The purpose of this study was to investigate the efficacy and safety of 'docetaxel-5-FU-cisplatin' combination chemotherapy as a first-line treatment in patients with metastatic or recurrent gastric cancer. ... -
- CITED
-
- Close
- SHARE
-
- Close
- Combined blockade of HER2 and VEGF exerts greater growth inhibition of HER2-overexpressing gastric cancer xenografts than individual blockade
-
Singh R, Kim WJ, Kim PH, Hong HJ
- KMID: 2154271
- Exp Mol Med.
- 2013 Nov;45(11):e52.
Gastric cancer overexpressing the human epidermal growth factor 2 (HER2) protein has a poor outcome, although a combination of chemotherapy and the anti-HER2 antibody trastuzumab has been approved for the... -
- CITED
-
- Close
- SHARE
-
- Close
